SCIENTIFIC INFORMATION
Sponsor Symposium
Moderator
Dr Jensen Ng
Symposium Title
Treating Critically-ill patients in an era of increased Gram-negative bacterial resistance – challenging the standard approach
Objectives
- Address the issue of multi-drug resistance in Gram negative bacteria, with a focus on resistance mechanisms of increasing concern
- Discuss the importance of early adequate therapy against the backdrop of high patient mortality and risk factors for infection
- Explore the challenges faces by ICU specialists in identifying and treating critically-ill patients with infections due to MDR Gram-negative bacteria
- Challenge the standard of care and discuss the rationale for the use of ceftazidime-avibactam in treating this patient group versus existing therapies
- Share knowledge on the use of ceftazidime-avibactam in real-world clinical practice
Agenda
1250 – 1255 | Welcome & Introduction | Dr Jensen Ng |
1255 – 1310 | Considerations for MDR Gram-negative infections in critically-ill patients in Asia | Dr Asok Kurup |
1310 – 1325 | Optimizing Antibiotic Treatment in the ICU: A Beta-lactam/Beta-lactamase inhibitor to consider? | Dr Kenneth Chan |
1325 – 1330 | Q&A | All |